Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,482 | -8,654 | N/A | -49,696 | N/A |
| Depreciation Amortization | 53 | 424 | N/A | 978 | N/A |
| Other Working Capital | 6,796 | -198 | N/A | -2,811 | N/A |
| Other Operating Activity | 2,632 | 588 | 0 | -1,140 | 0 |
| Operating Cash Flow | $-6,001 | $-7,840 | $N/A | $-52,669 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,925 | 104,925 | N/A | -84,914 | N/A |
| PPE Investments | 47 | 47 | N/A | 62 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -51,115 | N/A |
| Purchase Sale Intangibles | -7 | -7 | N/A | -48 | N/A |
| Other Investing Activity | -7 | -7 | 0 | -48 | 0 |
| Investing Cash Flow | $104,965 | $104,965 | $N/A | $-136,015 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61,714 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -335 | N/A |
| Other Financing Activity | -966 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $60,748 | $N/A | $N/A | $-335 | $N/A |
| Exchange Rate Effect | 89 | 16 | N/A | 573 | N/A |
| Beginning Cash Position | 68,263 | 68,263 | N/A | 310,667 | N/A |
| End Cash Position | 228,064 | 165,404 | N/A | 68,263 | N/A |
| Net Cash Flow | $159,801 | $97,141 | $N/A | $-242,404 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,001 | -7,840 | N/A | -52,669 | N/A |
| Free Cash Flow | -6,001 | -7,840 | 0 | -52,669 | 0 |